Literature DB >> 17512814

Sialylation of cell surface glycoconjugates is essential for osteoclastogenesis.

Masahiko Takahata1, Norimasa Iwasaki, Hiroaki Nakagawa, Yuichiro Abe, Takuya Watanabe, Manabu Ito, Tokifumi Majima, Akio Minami.   

Abstract

Sialic acid, which is located at the end of the carbohydrate moiety of cell surface glycoconjugates, is involved in many biologic responses, such as intercellular reactions and virus-cell fusion, especially in hematopoietic cells. Here we provide experimental evidence that the sialic acid of cell surface glycoconjugates has a role in osteoclast differentiation. Lectin histochemical study demonstrated the existence of both alpha (2,3)-linked-sialic acid and alpha (2,6)-linked-sialic acid in mouse bone marrow-derived macrophages and in the RAW264.7 macrophage cell line, which are osteoclast precursors. Flow cytometric analysis of surface lectin staining revealed the kinetics of these sialic acids during osteoclastogenesis: alpha (2,3)-linked-sialic acid was abundantly expressed throughout osteoclastogenesis, whereas alpha (2,6)-linked-sialic acid levels declined at the terminal stage of osteoclast differentiation. To investigate the role of sialic acid in osteoclast differentiation, we performed an osteoclastogenesis assay with or without exogenous sialidase treatment. Desialylated cells formed TRAP-positive mononuclear cells, but did not become multinuclear cells despite the normal expression of osteoclast markers such as cathepsin K, integrin beta3, and nuclear factor-ATc1. Flow cytometric analysis also demonstrated that exogenous sialidase effectively removed alpha (2,6)-linked-sialic acid, but only slightly changed the alpha (2,3)-linked-sialic acid content, suggesting that alpha (2,6)-linked-sialic acid might be involved in osteoclast differentiation. Findings from knockdown analysis using small interfering RNA oligonucleotides against alpha 2,6-sialyltransferase support this idea: alpha (2,6)-linked-sialic acid-deficient cells markedly inhibit the formation of multinuclear osteoclasts. Our findings suggest that alpha (2,6)-linked-sialic acid of cell surface glycoconjugates has a role in osteoclast differentiation, possibly via its role in the cell-cell fusion process.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17512814     DOI: 10.1016/j.bone.2007.03.016

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  13 in total

Review 1.  RNA therapeutics targeting osteoclast-mediated excessive bone resorption.

Authors:  Yuwei Wang; David W Grainger
Journal:  Adv Drug Deliv Rev       Date:  2011-09-10       Impact factor: 15.470

2.  Mechanism and function of monoclonal antibodies targeting siglec-15 for therapeutic inhibition of osteoclastic bone resorption.

Authors:  Matthew Stuible; Anna Moraitis; Annie Fortin; Stefan Saragosa; Aida Kalbakji; Mario Filion; Gilles B Tremblay
Journal:  J Biol Chem       Date:  2014-01-20       Impact factor: 5.157

3.  Lysosomal storage of oligosaccharide and glycosphingolipid in imino sugar treated cells.

Authors:  Stephanie D Boomkamp; J S Shane Rountree; David C A Neville; Raymond A Dwek; George W J Fleet; Terry D Butters
Journal:  Glycoconj J       Date:  2010-02-26       Impact factor: 2.916

4.  Siglec-15 protein regulates formation of functional osteoclasts in concert with DNAX-activating protein of 12 kDa (DAP12).

Authors:  Norihiro Ishida-Kitagawa; Kunitaro Tanaka; Xilinqiqige Bao; Takanori Kimura; Tadashi Miura; Yoshiki Kitaoka; Kouhei Hayashi; Mizuho Sato; Masahiro Maruoka; Takuya Ogawa; Jun Miyoshi; Tatsuo Takeya
Journal:  J Biol Chem       Date:  2012-03-26       Impact factor: 5.157

5.  Cell surface sialic acid inhibits Cx43 gap junction functions in constructed Hela cancer cells involving in sialylated N-cadherin.

Authors:  Jing Li; Lei Cheng; Li-juan Wang; Hong-chun Liu; Li Li; Xiao-lu Wang; Mei-yu Geng
Journal:  Mol Cell Biochem       Date:  2010-08-29       Impact factor: 3.396

6.  Glycomics of bone marrow-derived mesenchymal stem cells can be used to evaluate their cellular differentiation stage.

Authors:  Annamari Heiskanen; Tia Hirvonen; Hanna Salo; Ulla Impola; Anne Olonen; Anita Laitinen; Sari Tiitinen; Suvi Natunen; Olli Aitio; Halina Miller-Podraza; Manfred Wuhrer; André M Deelder; Jari Natunen; Jarmo Laine; Petri Lehenkari; Juhani Saarinen; Tero Satomaa; Leena Valmu
Journal:  Glycoconj J       Date:  2008-11-27       Impact factor: 2.916

Review 7.  Influenza virus replication in macrophages: balancing protection and pathogenesis.

Authors:  Troy D Cline; Donald Beck; Elizabeth Bianchini
Journal:  J Gen Virol       Date:  2017-09-08       Impact factor: 3.891

8.  Phenotype-related differential alpha-2,6- or alpha-2,3-sialylation of glycoprotein N-glycans in human chondrocytes.

Authors:  S Toegel; M Pabst; S Q Wu; J Grass; M B Goldring; C Chiari; A Kolb; F Altmann; H Viernstein; F M Unger
Journal:  Osteoarthritis Cartilage       Date:  2009-09-22       Impact factor: 6.576

9.  N-acetylglucosamine suppresses osteoclastogenesis in part through the promotion of O-GlcNAcylation.

Authors:  Tomoharu Takeuchi; Moyuko Nagasaka; Miyuki Shimizu; Mayumi Tamura; Yoichiro Arata
Journal:  Bone Rep       Date:  2016-02-03

Review 10.  Siglec-15: a potential regulator of osteoporosis, cancer, and infectious diseases.

Authors:  Takashi Angata
Journal:  J Biomed Sci       Date:  2020-01-03       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.